TickerFacts.

Brainstorm Cell Therapeutics Inc. (BCLI): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Older than the company's other figures. The latest Free Cash Flow is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Capital Expenditures, which Free Cash Flow is computed from, under the concepts TickerFacts maps.

-$20.48M
Year ended 2023-12-31
2010-12-31: -$2.07M2011-12-31: -$2.27M2012-12-31: -$3.02M2013-12-31: -$4.16M2014-12-31: -$4.65M2015-12-31: -$7.45M2016-12-31: -$5.96M2017-12-31: -$2.54M2018-12-31: -$12.76M2019-12-31: -$11.72M2020-12-31: -$35.57M2021-12-31: -$26.59M2022-12-31: -$19.35M2023-12-31: -$20.48M-$20.48M
2010-12-31 Free Cash Flow (USD) 2023-12-31
Period endedFree Cash FlowChange YoYSource filing
2023-12-31-$20.48Mn/m2025-03-31, From 2023-01-01
2022-12-31-$19.35Mn/m2024-04-01, From 2022-01-01
2021-12-31-$26.59Mn/m2023-03-30, From 2021-01-01
2020-12-31-$35.57Mn/m2022-03-28, From 2020-01-01
2019-12-31-$11.72Mn/m2021-02-04, From 2019-01-01
2018-12-31-$12.76Mn/m2020-02-18, From 2018-01-01
2017-12-31-$2.54Mn/m2019-04-01, From 2017-01-01
2016-12-31-$5.96Mn/m2018-03-08, From 2016-01-01
2015-12-31-$7.45Mn/m2017-03-29, From 2015-01-01
2014-12-31-$4.65Mn/m2016-03-09, From 2014-01-01
2013-12-31-$4.16Mn/m2015-03-26, From 2013-01-01
2012-12-31-$3.02Mn/m2014-03-27, From 2012-01-01
2011-12-31-$2.27Mn/m2013-03-14, From 2011-01-01
2010-12-31-$2.07Mn/a2012-03-15, From 2010-01-01